全文获取类型
收费全文 | 672篇 |
免费 | 56篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 24篇 |
妇产科学 | 39篇 |
基础医学 | 84篇 |
口腔科学 | 6篇 |
临床医学 | 119篇 |
内科学 | 118篇 |
皮肤病学 | 10篇 |
神经病学 | 68篇 |
特种医学 | 25篇 |
外科学 | 55篇 |
综合类 | 5篇 |
一般理论 | 1篇 |
预防医学 | 77篇 |
眼科学 | 4篇 |
药学 | 22篇 |
肿瘤学 | 58篇 |
出版年
2023年 | 8篇 |
2022年 | 9篇 |
2021年 | 28篇 |
2020年 | 18篇 |
2019年 | 32篇 |
2018年 | 26篇 |
2017年 | 27篇 |
2016年 | 22篇 |
2015年 | 18篇 |
2014年 | 27篇 |
2013年 | 30篇 |
2012年 | 53篇 |
2011年 | 58篇 |
2010年 | 32篇 |
2009年 | 30篇 |
2008年 | 32篇 |
2007年 | 45篇 |
2006年 | 32篇 |
2005年 | 44篇 |
2004年 | 37篇 |
2003年 | 25篇 |
2002年 | 19篇 |
2001年 | 9篇 |
2000年 | 18篇 |
1999年 | 13篇 |
1998年 | 3篇 |
1997年 | 4篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 4篇 |
1992年 | 4篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1976年 | 3篇 |
1974年 | 1篇 |
1965年 | 1篇 |
1948年 | 1篇 |
排序方式: 共有728条查询结果,搜索用时 15 毫秒
11.
MEK kinase 1 activity is required for definitive erythropoiesis in the mouse fetal liver 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Bonnesen B Orskov C Rasmussen S Holst PJ Christensen JP Eriksen KW Qvortrup K Odum N Labuda T 《Blood》2005,106(10):3396-3404
12.
J L Teruel F Lia?o M del Hoyo A Rocamora E Gómez Mampaso C Quereda J Ortu?o 《International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association》1985,53(3):410-411
A 40-year-old woman on chronic hemodialysis had been diagnosed as having lepromatous leprosy at the age of 17 and treated for 15 years with sulfones. She remained clinically free of leprosy during 19 months of hemodialysis and then underwent successful renal transplantation. Fourteen months after surgery, recurrence of leprosy was observed. In spite of immunosuppression, the skin lesions healed with sulfone treatment. Renal transplantation is a useful treatment in patients with leprosy and chronic renal failure. 相似文献
13.
Anne‐Cathrine Østby Sophie Gubbels Gerben Baake Lars Peter Nielsen Casper Riedel Magnus Arpi 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2013,121(11):1097-1108
Our aim was to determine the frequency of 12 common respiratory viruses in patients admitted to intensive care units with respiratory symptoms, evaluate the clinical characteristics and to compare the results to routine microbiological diagnostics. Throat swabs from 122 intensive care‐patients >18 years with acute respiratory symptoms were collected upon admission and analysed with multiplex real‐time polymerase chain reaction, for 12 community respiratory viruses. Blood and respiratory tract specimens were analysed for bacteria and fungi upon clinicians' request. Clinical and paraclinical data were collected. Viruses were detected in 19 (16%) of the 122 study patients. Five virus‐positive patients (26%) had possible clinically relevant bacteria or fungi co‐detected. Patients with exacerbation in COPD were associated with a viral infection (p = 0.02). Other comorbidities, clinical and paraclinical parameters, and death were independent of a viral infection or co‐detection of bacteria/fungi. In conclusion, respiratory viruses were frequently detected in the patients. The investigated clinical and paraclinical parameters were not different in viral infections compared to other agents, thus respiratory viruses likely have similar impact on the clinical course as other agents. In 25% of the virus‐positive patients, polymicrobial aetiology was identified. Comprehensive and sensitive diagnostic methods should be emphasized to enhance respiratory diagnostics. 相似文献
14.
15.
16.
17.
18.
19.
Levinsen M Shabaneh D Bohnstedt C Harila-Saari A Jonsson OG Kanerva J Lindblom A Lund B Andersen EW Schmiegelow K;Nordic Society of Paediatric Haematology Oncology 《European journal of haematology》2012,88(1):78-86
Trimethoprim-sulfamethoxazole (TMP/SMX) is used in children with acute lymphoblastic leukemia (ALL) to prevent Pneumocystis pneumonia (PCP). We explored to which extent TMP/SMX influenced methotrexate (MTX)/6-mercaptopurine (6MP) dosage, myelosuppression, and event-free survival (EFS) during maintenance therapy. Of 447 study patients treated by the NOPHO ALL92 protocol, 120 patients received TMP/SMX continuously for 2-7 d/wk (TMP/SMX(2-7) ) and 287 patients never received TMP/SMX (TMP/SMX(never) ). Ten patients (all TMP/SMX(never) ) developed PCP, eight of which occurred within 7 months from the start of maintenance therapy. The TMP/SMX(2-7) group received lower oral 6MP doses than TMP/SMX(never) patients (50.6 vs. 63.9 mg/m(2) /d; P<0.001) but had lower absolute neutrophil counts (ANC) (median 1.7 vs. 2.0 × 10(9) /L; P<0.001). In Cox multivariate analysis, higher ANC levels (P=0.04) and male gender (P=0.06) were related to reduced EFS. ANC had no effect on EFS among TMP/SMX(2-7) patients (P=0.40) but did for TMP/SMX(never) patients (P=0.02). The difference in the effect on EFS between TMP/SMX(2-7) and TMP/SMX(never) patients was not significant (P=0.46). EFS did not differ between TMP/SMX(2-7) and TMP/SMX(never) patients (0.83 vs. 0.83; P=0.82). These results suggest that TMP/SMX is effective in preventing PCP and may have an antileukemic effect. TMP/SMX should be given the entire duration of maintenance therapy. 相似文献
20.
Carlen Reyes Francesc Formiga Marta Coderch Jordi Hoyo Gemma Ferriz Jordi Casanovas Rosa Monteserín Carlos Brotons Marta Rojas Irene Moral 《BONE》2013,52(2):557-561
ObjectiveTo determine whether there is an increased risk of hip fracture associated with the use of proton pump inhibitors in a Mediterranean area after adjusting for other potential risk factors.MethodsRetrospective multicenter case–control study carried out in 6 primary health care centers in Catalonia, Spain. Cases were patients aged 50 years and over with a fragility hip fracture registered between January 2007 and December 2010, matched with 2 controls by sex and age. Data collected: use of proton pump inhibitors (type, dosage) in the 5 years previous to the hip fracture, socio-demographic data, body mass index, alcohol and tobacco consumption as well as health conditions and drugs associated with an increase risk of fragility hip fracture.Results358 cases were matched with 698 controls. The mean age was 82 years old in both groups. Women represented 77.1% in the case group and 76.9% in the control group. Crude association between proton pump inhibitors and hip fracture was 1.44 (95% CI, 1.09–1.89) and adjusted OR was 1.24 (95% CI, 0.93–1.65). No association was found with the continuous or discontinuous use of proton pump inhibitors, OR 1.17 (95% CI, 0.77–1.79), and OR of 1.16 (95% CI, 0.85–1.60) respectively. No association was found when restricting the analysis by sex, OR of 1.19 (95% CI, 0.27–5.14) or by age, younger or older than 80 years, OR of 0.72 (95% CI, 0.24–2.15).ConclusionThe use of proton pump inhibitors was not associated with an increased risk of hip fracture after adjusting for other risk factors in a Mediterranean area. This result suggests the existence of protective environmental factors linked to this southern area of Europe that eventually could compensate for the potential harm produced by proton pump inhibitors. 相似文献